Microfluidiser processors for every drug

Microfluidics has introduced a new line of Microfluidizer high-shear fluid processors designed specifically for the pharmaceutical and biotechnology industries.

The comprehensive line of 24 standard pre-engineered models allows companies to meet specific processing requirements of the particular drug being manufactured.

The processors are offered in aseptic, enhanced, and basic versions, which are available in various pressure ranges and with two different motor sizes, 25 and 50 hp. All are guaranteed to accurately scale up from lab and pilot-scale Microfluidizer processors, and may be scaled up from other processors as well.

Microfluidizer processors are used to manufacture a wide range of drugs delivered through injectables, inhalables, parenterals or transdermals. The processors generate a controlled shear rate, which allows bacterial, plant, and mammalian cells to be safely and efficiently disrupted.

They also impart the highest shear rates of any fluid processor on the market today in order to achieve the desired product quality for nanoemulsions, nanodispersions, liposomes and nano/microencapsulation in the fewest number of passes.

Microfluidics product manager, Dave Gucwa said: "Every company's processing needs are different, and we can now offer variations that suit a wide variety of requirements in such parameters as pressure, temperature control, feed techniques, process monitoring, and FDA 21 CFR part 11 compliant data recordkeeping."

All 24 processors come with the Ultra Clean In Place (UCIP) system, eliminating the need for disassembly for cleaning (COP), as well as written certifications that all product contact surfaces have been ground to a 20Ra surface finish, electro-polished and passivated.